Fate Therapeutics(FATE) - 2023 Q4 - Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Conference Call February 26, 2024 5:00 PM ET Company Participants Scott Wolchko - President and Chief Executive Officer Edward Dulac - Chief Financial Officer Bob Valamehr - Chief Research and Development Officer Conference Call Participants Michael Yee - Jefferies Yigal Nochomovitz - Citigroup Tara Bancroft - TD Cowen Tazeen Ahmad - Bank of America Daina Graybosch - Leerink Partners Michael Ulz - Morgan Stanley Peter Lawson - Barclays Carolina Ibanez - ...